Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro.
Front Immunol
; 14: 1112505, 2023.
Article
in En
| MEDLINE
| ID: mdl-36969164
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Angiotensin-Converting Enzyme 2
/
SARS-CoV-2
/
COVID-19
Limits:
Humans
Language:
En
Journal:
Front Immunol
Year:
2023
Type:
Article
Affiliation country:
Germany